Clinical Trial Update: Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED) [Phase 3]

View source ↗

Summary

The Phase 3 study MK2452-001 evaluating preservative-free tafluprost for open-angle glaucoma and ocular hypertension has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Tafluprost (MK2452) (tafluprost)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-09-13